Vaccines

Research examining the development of vaccines

Published and Preprint Papers

Vaccine Types

Title

Altmetric

adenovirus vaccine

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.

adenovirus vaccine

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.

adenovirus vaccine

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

adenovirus vaccine

ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques

protein subunit vaccine, subunit vaccine

Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.

inactivated vaccine

Rapid development of an inactivated vaccine for SARS-CoV-2

adenovirus vaccine

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.

DNA vaccine protection against SARS-CoV-2 in rhesus macaques.